Saturday, July 27, 2024
HomeBusinessDr. Scott Gottlieb says the Covid delta surge may be the ‘final...

Dr. Scott Gottlieb says the Covid delta surge may be the ‘final wave’ in U.S.

Date:

Related stories

Guide to Using Essential Oils for Skincare

Essential oils are famous for skincare. They come from...

Signage for businesses – Services and their benefits

Signage is a form of advertising that conveys the...

OPSC Recruitment 2024: Apply Online for Latest Vacancies

The Odisha Public Service Commission (OPSC) has announced its...

Why It’s Important for Teachers to Teach Social and Emotional Skills

Academic knowledge alone is not enough to prepare students...

How Religion Supports and Shields Children’s Mental Health

In the UK today, many parents and foster carers...

[ad_1]

Dr. Scott Gottlieb told CNBC on Monday the current surge in Covid infections caused by the more contagious delta variant may be the “final wave” of the virus in the United States.

“I don’t think Covid is going to be epidemic all through the fall and the winter. I think that this is the final wave, the final act, assuming we don’t have a variant emerge that pierces the immunity offered by prior infection or vaccination,” the former Food and Drug Administration commissioner said on “Squawk Box.” “This is probably going to be the wave of infection that ends up affecting the people who refuse to get vaccinated.”

Gottlieb said Americans have a couple months remaining where they need to take pandemic-related precautions, particularly in northern U.S. states as cases begin to peak in the South, until the wave of infections begins to decrease again.

“I think this is going to be a difficult period right now,” he said. However, Gottlieb said the contagious nature of the delta variant and increased vaccination rates could change the trajectory of future infections.

“We’re going to reach some level of populationwide exposure to this virus, either through vaccination or through prior infection that’s going to stop circulating at this level, at this rate,” said Gottlieb, who led the FDA from 2017 to 2019 under the Donald Trump administration.

The seven-day average of new daily coronavirus cases in the U.S. is 108,624, according to a CNBC analysis of Johns Hopkins University data. That’s up 36% compared with one week ago. The highly transmissible delta variant, first identified in India, is estimated to comprise 83% of all sequenced Covid cases in the country, according to Centers for Disease Control and Prevention estimates.

See also  Nearly all deaths, hospitalizations among unvaccinated

With the surge in infections coinciding with school reopening plans in the fall, Gottlieb warned that schools may need to begin the year with heavier mitigation measures in place like mask-wearing, testing, physical distancing and gathering through pods. 

“The goal has to be to get schools open and keep them open, and we can’t expect to change all the behaviors in terms of what we’re doing with respect to mitigation in schools and get the same result, especially with this new delta variant which is more contagious, and is inevitably going to be hard to control in the schools,” said Gottlieb, who serves on the board of Covid vaccine maker Pfizer.

Large amounts of vaccinated people can still gather in a venue if there is some “semblance of a bubble” around it, he said. Vaccinated people who are getting infected are likely contracting the virus from unvaccinated people, and then spreading it to close contacts after being contagious for a brief window of time, the former FDA chief said.

Gottlieb said wearing a higher-quality mask, like the KN95 mask, is more important now as the virus is known to spread through aerosols and not droplets. A high-quality cloth mask affords only 20% protection from transmission, and most people don’t wear them well, he said.

“We are taking sort of an alpha mindset into a delta world, and it’s not going to work,” Gottlieb said, referring to the alpha coronavirus variant first detected in the U.K. last year. “We’re going to see that this delta variant is more difficult to control,” he said.

See also  Biogen to pay $900 million to settle drug kickback allegations

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings’ and Royal Caribbean’s “Healthy Sail Panel.”

[ad_2]

Source link

Bellie Brown
Bellie Brownhttps://businesstimes.org
Hi my lovely readers, I am Bellie brown editor and writer of Businesstimes.org. I write blogs on various niches such as business, technology, lifestyle., health, entertainment, etc as well as manage the daily reports of the website. I am very addicted to my work which makes me keen on reading and writing on the very latest and trending topics. One can check my more writings by visiting Cleartips.net

Latest stories